Skip to search formSkip to main contentSkip to account menu

Schedule III Substance

Known as: C-III, CIII, SPL DEA Schedule III 
A category of drugs that have less potential for abuse or addiction than Schedule I or II drugs and have a useful medical purpose.
National Institutes of Health

Related topics

Related topics

1 relation
Structured Product Labeling DEA Schedule Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
Variation at the lipoprotein lipase and apolipoprotein AI‐CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: Interaction between genotype…
The effects of polymorphisms in the lipoprotein lipase (LPL) gene (HindIII and S447X) and in the apolipoprotein (apo) AI‐CIII… 
1997
1997
Utilization of Recombinant Adenovirus and Dominant Negative Mutants to Characterize Hepatocyte Nuclear Factor 4-regulated Apolipoprotein AI and CIII Expression*
Using recombinant adenoviral vectors and a dominant negative mutant of HNF-4, we have examined the contribution of hepatocyte… 
Highly Cited
1994
Highly Cited
1994
Associations of genotypes at the apolipoprotein AI‐CIII‐AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses
Association studies were carried out in a sample of 86 patients from Sweden who had survived a myocardial infarction (MI) at a… 
1994
1994
Apo CIII gene transcription is regulated by a cytokine inducible NF-kappa B element.
Overproduction of Apo CIII causes elevated plasma triglyceride levels in transgenic animals and is associated with… 
Highly Cited
1988
Highly Cited
1988
Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease.
Highly Cited
1988
Highly Cited
1988
DNA polymorphisms of the apolipoprotein AII and AI-CIII-AIV genes: a study in men selected for differences in high-density-lipoprotein cholesterol concentration.
We have investigated the frequencies of RFLPs of the apolipoprotein (apo) AII gene and of the apo AI-CIII-AIV gene cluster in 109… 
Highly Cited
1981
Highly Cited
1981
Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia.
1980
1980
The distribution of apo C-II and apo C-III in very low density lipoproteins of normal and type IV subjects.
Highly Cited
1976
Highly Cited
1976
The synthesis of apoproteins of very low density lipoproteins isolated from the Golgi apparatus of rat liver.
The incorporation of [3H]leucine in vivo into very low density lipoproteins (VLDL) from the rat hepatic Golgi apparatus and serum… 
Highly Cited
1973
Highly Cited
1973
Nuclear magnetic resonance study of the rate of electron transfer between cytochrome c and iron hexacyanides.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)